© Versita Sp. z o.o. The quantitative analysis of Tolfenamic Acid (TA) both as a pure compound and in tablet dosage form has been carried out using FT-IR and UV spectroscopy. In the FT-IR method, a number of characteristic absorption peaks were examined that could be used for analytical purpose. The analysis was carried out by preparing calibration curves of peak height/area versus TA content using two points baseline correction with fixed location, and the data was also analyzed through PLS regression model. In the UV method, ethanolic solutions of the drug were analyzed at 288 nm (λ max ) using 480 as the value of A (1%, 1 cm) at the analytical wavelength. The results have been compared statistically for recovery, precision, accuracy and linearity with the British Pharmacopoeial titration method that showed good validity of both test procedures. The two test methods exhibited good recovery of TA with an accuracy of 99.75-100.83% and 99.53-100.11% by FTIR spectrometry for peak height and area respectively and 100.21% for UV method. However, UV spectrometry was found to be more accurate and precise on the basis of statistical evaluation and hence can be employed in the quality control of TA in pharmaceuticals as an alternative to the titration method.
Introduction
A number of analytical methods are employed in the pharmaceutical industry for the accurate quality control of pharmaceuticals. Among these methods, FT-IR and UV/visible spectroscopy are the two most widely used techniques. FTIR spectrometry is a well known method and is used for the identification of chemical and pharmaceutical substances. In the recent past the use of FT-IR spectroscopy with appropriate software has been used for solving different problems related to analytical development. In addition to accuracy, this technique is also known for its low cost, simplicity, nondestructiveness and rapidity for qualitative analysis [1] [2] [3] . In view of these advantages, FT-IR spectroscopy has also been employed for the quantitative determination of few drugs (e.g. dimethicone, bucillamine, ibuprofen, niflumic acid, diazepam, lorazepam, etc.) both as raw material and in the finished dosage forms [3] [4] [5] [6] [7] [8] . UV/visible spectroscopy is another technique that is known for its extensive applicability, high sensitivity, selectivity, accuracy, simplicity and convenience in quantitative analysis of drugs and their dosage forms [9] . Tolfenamic acid (2-[(3-Chloro-2-methylphenyl) amino] benzoic acid) is a non-steroidal anti-inflammatory drug (NSAID) which belongs to the family of fenamates (Fig. 1) . Recent studies have shown that tolfenamic acid (TA) also possesses anticancer activity and has been investigated in a number of studies conducted against different types of cancers [10] [11] [12] . The latest studies have also reported some potential of this drug for slowing down the progression of Alzheimer's disease [13, 14] . In addition, some antibacterial activity of TA against H.
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Quantitative determination of tolfenamic acid and its pharmaceutical formulation using FTIR and UV spectrometry pylori has also been observed when combined with bismuth (III) [15] . So far TA is available only in tablet and capsule forms in UK for human use whereas a solution for injection is available for veterinary purposes [16] [17] [18] .
TA occurs as a white or slightly yellow crystalline powder and is practically insoluble in water. The official pharmacopoeial assay method for TA involves direct titration against sodium hydroxide [19] . FT-IR spectroscopy has been employed for the characterization and identification of TA and its different polymorphic forms [20] [21] [22] [23] but to date, no attempt has been made to apply this technique for the quantitative determination of TA and its dosage forms. Similarly, UV spectroscopy has also been used to analyze TA in the presence of different polymers [21, 24, 25] but the literature lacks information regarding the use of the technique for the purpose of quality control of TA as raw material and in its pharmaceutical dosage forms. Therefore, this study aims to develop simple, rapid, inexpensive and accurate FT-IR and UV methods for the determination of TA both in pure compound and in dosage forms with comparable or better accuracy and precision compared to the official titration method.
Experimental procedure

Materials
Tolfenamic acid (99.97%) and potassium bromide (KBr) of FT-IR grade (≥99%) were purchased from Sigma-Aldrich Company Ltd. (Dorset, UK) and ethanol (99.99%) from Fisher Scientific Inc. (Loughborough, UK). All other chemicals and solvents used in this study were of analytical grade. Clotam ® Rapid tablets were procured from a local pharmacy.
Sample preparation of Clotam
® tablets
Each Clotam ® tablet contains 200 mg of TA in it. A total of 20 tablets were accurately weighed, finely powdered and each sample from the powdered tablet was prepared using average equivalent weight calculations. The average weight of each tablet was found to be around 370 mg thus TA forms the bulk of the weight, i.e., ~55%.
FT-IR spectroscopy
The conventional KBr discs were prepared for both pure TA and Clotam ® . The samples were prepared by accurately weighing the drug and KBr on an analytical balance followed by grinding and mixing them together in an agate mortar and pestle. For each disc the ratio of the drug and KBr was set in such a manner that the final amount makes up the total of 200 mg. The resultant mixture was subjected to pressure in a die using an Atlas TM 15T manual hydraulic press (Specac, UK). All discs were made at a constant pressure of 9 tons with a uniform thickness of 1 mm and diameter of 13 mm.
The spectra of all the samples were collected using a Nicolet Nexus FT-IR spectrophotometer (Thermo Fisher Scientific Inc., USA). Each spectrum was obtained in a range of 4000-400 cm -1 by performing 64 scans at a spectral resolution of 4 cm -1 . The spectra were collected using Omnic 7.4 software whereas the peak height and area measurements were carried out by the help of built-in TQ Analyst chemometric software (Professional Edition, Thermo Fisher Scientific Inc., USA) using two point baseline correction with fixed location. The calibration curves were prepared using a content range from 0.5-2.0 mg of pure TA per disc.
The Partial least squares (PLS) regression was also developed using Unscrambler ® X software (CAMO, Norway). Spectral regions representing the selected peaks were defined as the dependent variable, while TA concentrations from standard reference measurements were defined as the independent variable.
UV spectroscopy
All spectral measurements were performed on Lambda 900 UV/visible/NIR spectrophotometer (Perkin-Elmer, USA) using quartz cells of 1 cm path length. Ethanolic solutions for both pure TA and Clotam ® were freshly prepared and measured against a background spectrum with the same solvent in the region 400-250 nm. The calibration curves were prepared using a concentration range of 0.5-2.6 mg% of pure TA.
Titrimetric analysis
Titration of the pure TA and Clotam ® was performed according to the official method described in the British Pharmacopoeia [19] . This method requires 200 mg of active drug dissolved in 100 mL of ethanol and titrated against 0.1 N sodium hydroxide solution using phenol red as indicator. Sodium hydroxide, 0.1 N, 1 mL is equivalent to 26.17 mg of TA. 
Results and discussion
Quantitative determination of TA by FT-IR spectroscopy
FT-IR spectra of TA
TA contains a chloro, methyl phenyl ring and a benzoic acid ring in its structure that are linked together by a secondary amine (Fig. 1) . The FT-IR spectrum of TA is shown in Fig. 2a where the characteristic peaks for the amino group can be observed at 3342-3340 cm -1 for its stretching vibration and at about 1500 cm -1 for its bending vibration. The carbonyl and benzene ring stretching vibrations could be observed around 1661 and 1582 cm -1 , respectively. The bands in the range of 1440-1400 cm -1 in the spectra are particularly observed due to the presence of CH 3 symmetric stretching whereas the peaks at about 1267 and 749 cm -1 may be attributed to C-H and C-N deformation, respectively. However, the region between 540-400 cm -1 is known for C-Cl deformation and stretching vibrations. Similar identification of the characteristic peaks of TA in the same regions has also been reported previously [20, 22, 23] . The regions between 3350-3300 cm -1 and 1700-1300 cm -1 are also of prime importance in the identification of different polymorphic forms of TA [20] [21] [22] [23] .
In the FT-IR spectra of TA (Fig. 2a) and its tablet dosage form, i.e., Clotam ® ( Fig. 2b) , not much difference was observed in the absorption bands of the two compounds. Both forms appeared identical in their characteristic bands that can be used for the purpose of quantitative determination. Usually, a variety of pharmaceutical excipients are used in the preparation of dosage forms which may interfere with the characteristic bands of the active ingredient. In the case of mixtures of pharmaceuticals containing the active ingredients and adjuvants, some difficulty may be experienced in the choice of appropriate analytical wavelengths for quantitative analysis as a result of the overlapping of bands and absorbance contribution due to the adjuvants. However, in the case of Clotam ® no such interference was observed which may be due to the presence of active ingredient in bulk amount, i.e., ~55%. The remaining ~45% is composed of a variety of excipients, each in a small proportion, which on further dilution with KBr becomes undetectable and showed negligible interference.
Selection of the bands for quantitative determination of TA
The selection of bands for the purpose of quantitative determination of TA was carried out considering those characteristic peaks where a gradual difference in the peak intensity was observed with respect to the change in TA concentration. Seven characteristic peaks, i.e., 3340, 1661, 1582, 1500, 1438, 1267 and 750 cm -1 were selected (Fig. 3) and their baseline correction regions are presented in Tables 1 and 2 . The peak height and area of all the selected peaks were calculated individually to prepare the calibration curves (Figs. 4a, 4b) and the results are presented in Tables 1 and 2 
Validation and statistical interpretation of the analytical data
Validation of the analytical data was carried out by determining linearity, accuracy, precision, limit of detection (LOD) and limit of quantification (LOQ) with respect to peak height and area (Tables 1 and  2 ). The results are found to be linear in the range of 0.5-2.0 mg for TA by both peak height (Fig. 4a ) and peak area (Fig. 4b) determinations at the selected bands. The values of correlation coefficient for peak height are in the range of 0.9779-0.9989. The recovery at all the studied peaks is within 91-109% and shows that the height of selected peaks corresponds well to the changes in TA concentration. However, among all the studied bands for height, comparatively better statistical results have been obtained for the peak at 1438 cm -1 that indicated the lowest standard deviation value of ±2.028 for accuracy and better precision with a RSD of 2.030%. The peaks at 750 and 1582 cm -1 also exhibited comparable statistical results (Table 1 ). In the case of peaks selected with respect to area, a good linearity has been observed at all the studied peaks with a correlation coefficient in the range of 0.9860-0.9984 and a recovery of 89-107%. Among all the selected regions for peak area, comparatively better statistical results have been obtained in the region 1530-1470 cm -1 that show the standard deviation of ±2.601 for accuracy with a RSD of 2.608% for precision (Table 2) .
PLS regression method has been used for constructing predictive models when there are many explanatory variables that are highly collinear [26] . Therefore, the data was also subjected to PLS regression analysis and a model was constructed over the spectral range encompassing all individually defined peaks. The model performed well for the TA calibration range of 0.5-2.0 mg showing that the absorbance within spectral range correlates well with the content of TA in the prepared samples (Fig. 4c) . The construction of such accurate models from raw data is advantageous in the quantitative determination of active pharmaceutical ingredient as pure compound and in dosage forms. Cross validation of type leave-one-out was performed that produced an RMSEC of 0.026 with the highest error from 1.5 mg samples (Fig. 4c) . The comparison of several cross validation methods is a common practice and indicates model stability.
Quantitative determination of TA by UV spectroscopy
The overlay absorption spectra of varying concentrations of TA in ethanol are presented in Fig. 5 . The absorption maximum of the most intense peak of TA was observed at 288 nm whereas the other comparatively less intense peak occurred at 343 nm. The calibration data showed that the Beer's law is obeyed over the studied concentration range of 0.5-2.6 mg% with a good linearity (y = 0.4797x + 0.0031, R² = 0.9995) at 288 nm. The validation data of the method exhibited an accuracy of 100.21% within a recovery range of about 99-102% and a precision of 1.165% RSD (Table 3) . The absorption spectrum of TA extracted from the tablets of Clotam ® is shown along with pure TA in Fig. 5 . It exhibits the same absorption maximum at 288 nm as that of the pure sample. The slight difference in the 350-300 nm region may be due to the interference or/and interaction of the excipients in that region. 
Recovery comparison of TA for both pure compound and dosage form by different analytical techniques
In order to find the best method of analysis for the quantitative determination of TA, the results obtained by FT-IR and UV spectroscopy are compared with the standard titration method given in the British Pharmacopoeia [19] . In addition to the pure drug material, the recovery of TA in its dosage form (Clotam ® tablets) has also been confirmed and compared (Table 4) . The mean percentage recoveries of TA both in the pure and tablet forms by the three analytical techniques have been found in the range of 96-101%. The range indicates that all test methods are specific for TA as pure compound as well as in the dosage forms and can be used for the assay of TA efficiently. However, in order to evaluate these results statistically for the accuracy and precision, the two test methods, i.e., FT-IR and UV spectroscopy, were compared with the standard titration method (Table 4 ). This comparison was made by calculating the P-values (significance level) from the F and t tests in order to ascertain the precise probability. The P(F<=f) and P(T<=t) values obtained at 95% confidence interval (P<0.05) indicate a nonsignificant difference in the precision as well as in the results of the test and standard methods, respectively (Table 4 ). The variations may be due to the random errors in each case. Thus, the accuracy and precision of the FT-IR and UV spectrometric methods are comparable to that of the official titrimetric method for the quantitative determination of TA as pure compound and in tablets.
Both FT-IR and UV spectrometric methods possess some additional advantages over the titrimetric method such as a small sample size is required with low concentration of TA, easier sample preparation, less time consuming and comparatively cost effective, as no large amount of active, solvent and indicator are required. Similarly, the methods can also be used in determining the purity and identity of the active drug, which is not possible by titration. In this study, UV spectroscopy demonstrated better results than the FT-IR spectroscopy. The main sources of error in FT-IR analysis could be due to the repeated weighing, nonuniform distribution of TA in the sample and the use of manual hydraulic press for the preparation of KBr discs giving some thickness variations that have resulted in higher standard deviation for recovery of TA both as pure compound and in the dosage form. However, in future, additional statistical evaluation by employing more brands of TA and studying the specificity of the methods in the presence of impurities / degradation products will further help in proving the validity of these test methods.
Conclusion
The official method for the assay of TA in the British Pharmacopoeia involves acid-base titration. An attempt has been made in this study to quantify TA as pure compound and in the dosage form by FT-IR and UV spectroscopy. The validation data of both techniques exhibited good estimation of the drug with acceptable linearity, accuracy and precision. However, the comparison of the two spectrometric techniques with the standard titration method revealed both test methods to be equally useful for the determination of TA as pure compound and in the tablets. The results of the UV method are more accurate and precise compared to the FT-IR method. Thus the UV method can be used as an alternative to the official titration method for the quality control of TA in pharmaceuticals.
